Infection control or formulary control: what is the best tool to reduce nosocomial infections due to methicillin-resistant Staphylococcus aureus?

Clin Infect Dis. 2006 Mar 15;42(6):785-7. doi: 10.1086/500327. Epub 2006 Feb 7.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / therapeutic use
  • Cross Infection / drug therapy*
  • Cross Infection / epidemiology
  • Cross Infection / microbiology
  • Fluoroquinolones / administration & dosage*
  • Fluoroquinolones / therapeutic use
  • Hospitalization
  • Humans
  • Hygiene
  • Infection Control*
  • Methicillin Resistance*
  • Microbial Sensitivity Tests
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / epidemiology
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / isolation & purification*

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones